84 related articles for article (PubMed ID: 8219133)
1. [31P-MR spectroscopy of liver diseases with reference to variable pulse recovery times].
Brinkmann G; Melchert UH; Lalk G; Heller M
Rofo; 1993 Nov; 159(5):412-8. PubMed ID: 8219133
[TBL] [Abstract][Full Text] [Related]
2. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
[TBL] [Abstract][Full Text] [Related]
3. [In vivo 31-phosphorus magnetic resonance spectroscopy of liver diseases].
Brinkmann G; Melchert U; Förger K; Wunsch-Binder F; Heidemann H; Engemann R
Rofo; 1990 Aug; 153(2):204-8. PubMed ID: 2168078
[TBL] [Abstract][Full Text] [Related]
4. [The relationship between 31P magnetic resonance spectroscopy and the histopathology of livers of chronic viral hepatitis patients].
Wu B; Song B; Zhou XP; Yang Y; Lei XZ; Jiang LL
Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):338-41. PubMed ID: 17524264
[TBL] [Abstract][Full Text] [Related]
5. [Phosphorus 31-magnetic resonance spectroscopic studies of animal liver after extracorporeal shock wave lithotripsy].
Yokota H; Matoba M; Tatsuta N; Tonami H; Okimura T; Yamamoto I
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jul; 52(7):934-41. PubMed ID: 1508653
[TBL] [Abstract][Full Text] [Related]
6. [31P-MR spectroscopy of the human liver--the spectral indications of lymphoma infiltration].
Heindel W; du Mesnil de Rochemont R; Kugel H; Ernst S; Tesch H; Diehl V; Lackner K
Rofo; 1997 Jul; 167(1):62-70. PubMed ID: 9289045
[TBL] [Abstract][Full Text] [Related]
7. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
[TBL] [Abstract][Full Text] [Related]
8. Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy.
Noren B; Dahlqvist O; Lundberg P; Almer S; Kechagias S; Ekstedt M; Franzén L; Wirell S; Smedby O
Eur J Radiol; 2008 May; 66(2):313-20. PubMed ID: 17646074
[TBL] [Abstract][Full Text] [Related]
9. A study of T1-weighted 31phosphorus MR-spectroscopy from patients with focal and diffuse liver disease.
Brinkmann G; Melchert UH
Magn Reson Imaging; 1992; 10(6):949-56. PubMed ID: 1461092
[TBL] [Abstract][Full Text] [Related]
10. Adenosine triphosphate infusion increases liver energy status in advanced lung cancer patients: an in vivo 31P magnetic resonance spectroscopy study.
Leij-Halfwerk S; Agteresch HJ; Sijens PE; Dagnelie PC
Hepatology; 2002 Feb; 35(2):421-4. PubMed ID: 11826418
[TBL] [Abstract][Full Text] [Related]
11. Hepatic sugar phosphate levels reflect gluconeogenesis in lung cancer: simultaneous turnover measurements and 31P magnetic resonance spectroscopy in vivo.
Leij-Halfwerk S; Dagnelie PC; Van Den Berg JW; Wilson JH; Sijens PE
Clin Sci (Lond); 2000 Feb; 98(2):167-74. PubMed ID: 10657272
[TBL] [Abstract][Full Text] [Related]
12. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques.
Cox IJ; Menon DK; Sargentoni J; Bryant DJ; Collins AG; Coutts GA; Iles RA; Bell JD; Benjamin IS; Gilbey S
J Hepatol; 1992 Mar; 14(2-3):265-75. PubMed ID: 1323598
[TBL] [Abstract][Full Text] [Related]
13. Altered hepatic gluconeogenesis during L-alanine infusion in weight-losing lung cancer patients as observed by phosphorus magnetic resonance spectroscopy and turnover measurements.
Leij-Halfwerk S; van den Berg JW; Sijens PE; Wilson JH; Oudkerk M; Dagnelie PC
Cancer Res; 2000 Feb; 60(3):618-23. PubMed ID: 10676645
[TBL] [Abstract][Full Text] [Related]
14. [31P-cardio-MR-spectroscopy in myocardial insufficiency].
Krahe T; Schindler R; Neubauer S; Ertl G; Horn M; Lackner K
Rofo; 1993 Jul; 159(1):64-70. PubMed ID: 8334261
[TBL] [Abstract][Full Text] [Related]
15. [Spectroscopic imaging of the human liver using 3D CSI: optimization and application in patients with metastatic uvea melanoma].
Beer M; Winkelmann V; Becker JC; Terheyden P; Stenzel M; Bröcker EB; Hahn D; Köstler H
Rofo; 2009 Jan; 181(1):60-6. PubMed ID: 19085691
[TBL] [Abstract][Full Text] [Related]
16. Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging.
Li CW; Negendank WG; Murphy-Boesch J; Padavic-Shaller K; Brown TR
NMR Biomed; 1996 Jun; 9(4):141-55. PubMed ID: 9015801
[TBL] [Abstract][Full Text] [Related]
17. Effect of cytochrome P450 induction on phosphorus metabolites and proton relaxation times measured by in vivo 31P-magnetic resonance spectroscopy and 1H-magnetic resonance relaxometry in human liver.
Block W; Reichel C; Träber F; Skodra T; Lamerichs R; Kreft B; Spengler U; Sauerbruch T; Schild HH
Hepatology; 1997 Dec; 26(6):1587-91. PubMed ID: 9398002
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling.
Sevastianova K; Hakkarainen A; Kotronen A; Cornér A; Arkkila P; Arola J; Westerbacka J; Bergholm R; Lundbom J; Lundbom N; Yki-Järvinen H
Radiology; 2010 Aug; 256(2):466-73. PubMed ID: 20656836
[TBL] [Abstract][Full Text] [Related]
19. 31P magnetic resonance spectroscopy of the liver: correlation with standardized serum, clinical, and histological changes in diffuse liver disease.
van Wassenaer-van Hall HN; van der Grond J; van Hattum J; Kooijman C; Hoogenraad TU; Mali WP
Hepatology; 1995 Feb; 21(2):443-9. PubMed ID: 7843719
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of magnetic resonance spectroscopy of the liver in patients receiving long-term parenteral nutrition.
Woodward JM; Priest AN; Hollingsworth KG; Lomas DJ
JPEN J Parenter Enteral Nutr; 2009; 33(6):669-76. PubMed ID: 19587386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
